User profiles for Gian Marco Podda

Gian Marco Podda

Professore Associato di Medicina Interna, Direttore UOC Medicina Generale 2, San Paolo …
Verified email at unimi.it
Cited by 2330

ANKRD26-related thrombocytopenia and myeloid malignancies

…, KY Niederhoffer, JB Bussel, GM Podda… - Blood, The Journal …, 2013 - ashpublications.org
Since the discovery that mutations in the 5! untranslated region (UTR) of ANKRD26 are
responsible for an autosomal-dominant form of thrombocytopenia (ANKRD26-RT), 1 21 affected …

Risk of venous thromboembolism after air travel: interaction with thrombophilia and oral contraceptives

…, E Taioli, T Battaglioli, GM Podda… - Archives of internal …, 2003 - jamanetwork.com
Background Conflicting data are available on air travel as a risk factor for venous
thromboembolism. To our knowledge, there are no studies investigating whether individuals with …

[HTML][HTML] Bleeding risk of surgery and its prevention in patients with inherited platelet disorders

…, ML Lozano, P Zúñiga, C Flaujac, GM Podda… - …, 2017 - ncbi.nlm.nih.gov
Excessive bleeding at surgery is a feared complication in patients with inherited platelet
disorders. However, very few studies have evaluated the frequency of surgical bleeding in these …

[HTML][HTML] Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia

…, I Nichele, LD Notarangelo, T Pippucci, GM Podda… - …, 2014 - ncbi.nlm.nih.gov
Pregnancy in women with inherited thrombocytopenias is a major matter of concern as both
the mothers and the newborns are potentially at risk of bleeding. However, medical …

[HTML][HTML] Sensitivity of SARS-CoV-2 detection with nasopharyngeal swabs

…, G Casazza, G Costantino, GM Podda - Frontiers in Public …, 2021 - frontiersin.org
Background: SARS-CoV-2-infected subjects have been proven contagious in the symptomatic,
pre-symptomatic and asymptomatic phase. The identification of these patients is crucial …

Enoxaparin for thromboprophylaxis in hospitalized COVID‐19 patients: the X‐COVID‐19 randomized trial

N Morici, GM Podda, S Birocchi… - European journal of …, 2022 - Wiley Online Library
… Drafting of the manuscript: Marco Cattaneo, Nuccia Morici. Critical … : GianMarco Podda,
Simone Birocchi, Luca Bonacchini, Marco Merli, Michele Trezzi, Gianluca Massaini, Marco

High rates of pulmonary artery occlusions in COVID‐19. A meta‐analysis

S Birocchi, M Manzoni, GM Podda… - European Journal of …, 2021 - Wiley Online Library
Background COVID‐19 patients are considered at high risk of venous thromboembolism (VTE).
The real nature of pulmonary artery occlusions (PAO) in COVID‐19 has been questioned…

Prediction of optimal warfarin maintenance dose using advanced artificial neural networks

E Grossi, GM Podda, M Pugliano, S Gabba… - …, 2014 - Future Medicine
Background: In recent years, pharmacogenetic algorithms were developed for estimating
the appropriate dose of vitamin K antagonists. Aim: To evaluate the performance of new …

[HTML][HTML] Correlation between platelet phenotype and NBEAL2 genotype in patients with congenital thrombocytopenia and α-granule deficiency

…, PG Heller, P Noris, D De Rocco, GM Podda… - …, 2013 - ncbi.nlm.nih.gov
The gray platelet syndrome is a rare inherited bleeding disorder characterized by
macrothrombocytopenia and deficiency of alpha (α)-granules in platelets. The genetic defect …

Novel manifestations of immune dysregulation and granule defects in gray platelet syndrome

…, S Papadia, SJ Park, J Pasi, GM Podda… - Blood, The Journal …, 2020 - ashpublications.org
Gray platelet syndrome (GPS) is a rare recessive disorder caused by biallelic variants in
NBEAL2 and characterized by bleeding symptoms, the absence of platelet α-granules, …